Dr Reddy's Laboratories Revenue 2006-2021 | RDY

Dr Reddy's Laboratories annual/quarterly revenue history and growth rate from 2006 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Dr Reddy's Laboratories revenue for the quarter ending September 30, 2021 was $0.778B, a 17.7% increase year-over-year.
  • Dr Reddy's Laboratories revenue for the twelve months ending September 30, 2021 was $2.788B, a 20.05% increase year-over-year.
  • Dr Reddy's Laboratories annual revenue for 2021 was $2.594B, a 12% increase from 2020.
  • Dr Reddy's Laboratories annual revenue for 2020 was $2.316B, a 4.09% increase from 2019.
  • Dr Reddy's Laboratories annual revenue for 2019 was $2.225B, a 2.02% increase from 2018.
Dr Reddy's Laboratories Annual Revenue
(Millions of US $)
2021 $2,594
2020 $2,316
2019 $2,225
2018 $2,181
2017 $2,171
2016 $2,335
2015 $2,378
2014 $2,203
2013 $2,133
2012 $1,901
2011 $1,677
2010 $1,563
2009 $1,365
2008 $1,250
2007 $1,510
2006 $546
2005 $446
Dr Reddy's Laboratories Quarterly Revenue
(Millions of US $)
2021-09-30 $778
2021-06-30 $662
2021-03-31 $673
2020-12-31 $675
2020-09-30 $661
2020-06-30 $585
2020-03-31 $458
2019-12-31 $618
2019-09-30 $682
2019-06-30 $558
2019-03-31 $604
2018-12-31 $535
2018-09-30 $543
2018-06-30 $543
2018-03-31 $525
2017-12-31 $590
2017-09-30 $553
2017-06-30 $513
2017-03-31 $608
2016-12-31 $546
2016-09-30 $538
2016-06-30 $479
2016-03-31 $527
2015-12-31 $603
2015-09-30 $614
2015-06-30 $591
2015-03-31 $621
2014-12-31 $610
2014-09-30 $579
2014-06-30 $586
2014-03-31 $580
2013-12-31 $571
2013-09-30 $537
2013-06-30 $478
2013-03-31 $613
2012-12-31 $522
2012-09-30 $544
2012-06-30 $457
2012-03-31 $522
2011-12-31 $522
2011-09-30 $462
2011-06-30 $444
2011-03-31 $453
2010-12-31 $424
2010-09-30 $420
2010-06-30 $363
2010-03-31 $365
2009-12-31 $373
2009-09-30 $382
2009-06-30 $381
2009-03-31 $390
2008-12-31 $379
2008-09-30 $348
2008-06-30 $350
2008-03-31 $331
2007-12-31 $313
2007-09-30 $319
2007-06-30 $296
2007-03-31 $419
2006-12-31 $1,123
2006-09-30 $742
2006-06-30 $306
2006-03-31 $-228
2005-12-31 $130
2005-09-30 $132
2005-06-30 $128
2005-03-31 $95
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $9.206B $2.594B
Doctor Reddy's is an emerging global pharmaceutical company with proven research capabilities. They are vertically integrated with a presence across the pharmaceutical value chain. They produce finished dosage forms, active pharmaceutical ingredients and biotechnology products and market them globally, with focus on India, US, Europe and Russia. They conduct research in the areas of cancer, diabetes, cardiovascular, inflammation and bacterial infection
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $9.078B 3.46
Bausch Health Cos (BHC) Canada $8.349B 5.18